// App-Quantinova.ai

2799 : Population Pharmacokinetics of Eryaspase in Patients with Acute Lymphoblastic Leukemia or Pancreatic Adenocarcinoma

Researchers

Presenter

  • Frank Hoke

Principal Investigators

  • Kara Schmelzer

  • Jianping Zhang

  • Philip Lorenzi

  • Iman El-Hariry

Medical Centers

  • Clinical Pharmacology, Erytech Pharma, Cambridge, MA

  • Quantitative Clinical Development, Parexel International, Durham, NC

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Erytech Pharma, LYON, FRA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Acute lymphoblastic leukemia

  • Pancreatic cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Asparaginase

  • ERY001

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved